Alx Oncology Holdings (ALXO) Share-based Compensation (2019 - 2026)
Alx Oncology Holdings (ALXO) posted Share-based Compensation of $2.68 million for Q2 2026, up 25.6% from $2.14 million a year earlier and up 6.9% from the prior quarter.
Powered by 
Analysis
Alx Oncology Holdings (ALXO) Share-based Compensation (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Alx Oncology Holdings was $10.42 million, down 48.3% year-over-year; for FY2025, it came in at $12.58 million, down 53.6% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 18.3% (FY2020 to FY2025).
- In prior years, Alx Oncology Holdings' Share-based Compensation was $27.09 million in FY2024 (+3.1%), $26.27 million in FY2023 (+10.2%), $23.84 million in FY2022 (+71.3%) and $13.91 million in FY2021 (+156.0%).
- Quarterly Share-based Compensation has run from a low of $2.14 million in Q2 2025 to a high of $7.25 million in Q2 2024 over five years.
- On a year-over-year basis, Share-based Compensation increased in 1 of the last eight quarters, with an average decline of 31.7%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2021, with growth of 508.3%; the weakest was Q2 2025, with a decline of 70.5%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $2.51 million (Q1 2026), $2.71 million (Q4 2025) and $2.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Alx Oncology Holdings | 186.59 Mn | 186.59 Mn | - | 2.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.68 Mn |
| Mar 31, 2026 | 2.51 Mn |
| Dec 31, 2025 | 2.71 Mn |
| Sep 30, 2025 | 2.52 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 5.22 Mn |
| Dec 31, 2024 | 5.86 Mn |
| Sep 30, 2024 | 6.95 Mn |
| Jun 30, 2024 | 7.25 Mn |
| Mar 31, 2024 | 7.03 Mn |
| Dec 31, 2023 | 6.72 Mn |
| Sep 30, 2023 | 6.96 Mn |
| Jun 30, 2023 | 6.24 Mn |
| Mar 31, 2023 | 6.35 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 6.21 Mn |
| Jun 30, 2022 | 5.84 Mn |
| Mar 31, 2022 | 5.50 Mn |
| Dec 31, 2021 | 5.69 Mn |
| Sep 30, 2021 | 4.19 Mn |
API Access
Alx Oncology Holdings Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALXO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ALXO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALXO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();